101 related articles for article (PubMed ID: 22531488)
1. Non-opioid nociceptive activity of human dynorphin mutants that cause neurodegenerative disorder spinocerebellar ataxia type 23.
Watanabe H; Mizoguchi H; Verbeek DS; Kuzmin A; Nyberg F; Krishtal O; Sakurada S; Bakalkin G
Peptides; 2012 Jun; 35(2):306-10. PubMed ID: 22531488
[TBL] [Abstract][Full Text] [Related]
2. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
3. Altered secondary structure of Dynorphin A associates with loss of opioid signalling and NMDA-mediated excitotoxicity in SCA23.
Smeets CJ; Zmorzyńska J; Melo MN; Stargardt A; Dooley C; Bakalkin G; McLaughlin J; Sinke RJ; Marrink SJ; Reits E; Verbeek DS
Hum Mol Genet; 2016 Jul; 25(13):2728-2737. PubMed ID: 27260403
[TBL] [Abstract][Full Text] [Related]
4. Perturbations of model membranes induced by pathogenic dynorphin A mutants causing neurodegeneration in human brain.
Madani F; Taqi MM; Wärmländer SK; Verbeek DS; Bakalkin G; Gräslund A
Biochem Biophys Res Commun; 2011 Jul; 411(1):111-4. PubMed ID: 21712028
[TBL] [Abstract][Full Text] [Related]
5. Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sato T; Satoh S; Sakurada S; Marinova Z; Yakovleva T; Bakalkin G; Terenius L; Tadano T
Pain; 2005 Feb; 113(3):301-309. PubMed ID: 15661437
[TBL] [Abstract][Full Text] [Related]
6. [MK-801 suppresses dynorphin A (1-17)-induced facilitation of nociceptive responses to formalin in rats].
Qi WX; Lu CR
Sheng Li Xue Bao; 2003 Feb; 55(1):101-4. PubMed ID: 12598944
[TBL] [Abstract][Full Text] [Related]
7. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
8. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
[TBL] [Abstract][Full Text] [Related]
9. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
11. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.
Kuzmin A; Madjid N; Terenius L; Ogren SO; Bakalkin G
Neuropsychopharmacology; 2006 Sep; 31(9):1928-37. PubMed ID: 16292317
[TBL] [Abstract][Full Text] [Related]
12. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
13. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
15. Involvement of glial cells in the nociceptive behaviors induced by a high-dose of histamine administered intrathecally.
Mizoguchi H; Komatsu T; Iwata Y; Watanabe C; Watanabe H; Orito T; Katsuyama S; Yonezawa A; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Feb; 653(1-3):21-5. PubMed ID: 21118680
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
17. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
19. Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.
Bakalkin G; Watanabe H; Jezierska J; Depoorter C; Verschuuren-Bemelmans C; Bazov I; Artemenko KA; Yakovleva T; Dooijes D; Van de Warrenburg BP; Zubarev RA; Kremer B; Knapp PE; Hauser KF; Wijmenga C; Nyberg F; Sinke RJ; Verbeek DS
Am J Hum Genet; 2010 Nov; 87(5):593-603. PubMed ID: 21035104
[TBL] [Abstract][Full Text] [Related]
20. Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
Claye LH; Unterwald EM; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Apr; 277(1):359-65. PubMed ID: 8613942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
